Results 211 to 220 of about 69,470 (266)

Veterinary-specific breakpoints for ceftiofur applicable to canine <i>Escherichia coli</i>. [PDF]

J Clin Microbiol
Dang X, Chen S, Lyu H, Zou Z, Sun D, Yan L, Wang T, Huang C, Li Y, Ma S, Bai R, Jiang J, Zhai W, Wang L, Hu F, Wu C, Papich MG, Shen J, Martinez MN, Schwarz S, Xia Z, Wang Y.   +21 more
europepmc   +1 more source

Phenotypic and PCR-based analysis of antimicrobial resistance in heat-treated multidrug-resistant Salmonella spp. and Campylobacter jejuni isolated from raw chicken meat. [PDF]

Poult Sci
Al-Qadiri HM, Khataybeh B, Mayyas A, Al-Holy MA, Olaimat AN, Hamad I, Al-Alami N, Bakri FG, Zakaria H, Al-Qaisi M, Alsmairat TN, Nijmeh GY, Al-Akhras R, Rasco BA, Mahasneh ZMH.   +14 more
europepmc   +1 more source

Fluconazole Disk Diffusion on CHROMagar Candida Plus for Differentiation Between <i>Candidozyma auris</i> and <i>Candida parapsilosis</i>. [PDF]

J Fungi (Basel)
Israel S, Lellouche J, Ardda L, Israel A, Amit S, Ben-Ami R, Polacheck I, Moran-Gilad J, Korem M.   +8 more
europepmc   +1 more source

Isolation and characterization of Candida metapsilosis from foci of chronic pododermatitis in captive steppe eagles in Kazakhstan. [PDF]

PLoS One
Kukhar E, Bailina G, Nessipbayeva A, Sattarova R, Turkeyev M.   +4 more
europepmc   +1 more source

Comparison of two algorithms of APTT-based lupus anticoagulant assay, two Dilute Russell viper venom time reagents, and silica clotting time. [PDF]

PLoS One
Wongkrajang P, Pientong T, Hanyongyuth R, Tientadakul P.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Introducing the new face of CLSI M100 in 2023: An explanatory review

Indian Journal of Medical Microbiology, 2023
The CLSI annual update of its M100 document is eagerly awaited every year. This year's update, the M100-Ed33, was published in February, and will significantly affect clinical practices.To highlight and explain the rationale of the changes and their clinical impact.The major changes this year are mostly focused on PK/PD data, selective and cascade ...
Sumit Rai, Nidhima Aggarwal, Debabrata Dash   +2 more
exaly   +3 more sources

Manogepix (APX001A) In Vitro Activity against Candida auris: Head-to-Head Comparison of EUCAST and CLSI MICs.

Antimicrobial Agents and Chemotherapy, 2020
Fosmanogepix is a novel prodrug in a new class of antifungal agents. Manogepix is the active moiety. We evaluated the CLSI and EUCAST MICs of manogepix and eight comparators against Candida auris.
Anuradha Chowdhary, Maiken C Arendrup, Joseph Meletiadis   +2 more
exaly   +4 more sources